Creative Medical Technology Holdings, Inc. (CELZ) KPIs and segments

CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30

$0.62−0.01 (-2.08%)

Close on Nov 12, 2026Market cap $4.06MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Creative Medical Technology's business

Coming soon

This tab will track the numbers specific to Creative Medical Technology's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?